CompanyDeals

Jiangsu Nhwa Secures Exclusive Rights to Teva’s Austedo in China with $30 Million Deal

Policy / Regulatory

Guangdong Province Releases New Batch of Urgently Needed Drugs and Medical Devices for Greater Bay Area

CompanyDeals

Tencent Hands Over Two Former CSIG Employees to Authorities on Embezzlement Allegations

CompanyDrug

Sanofi’s Dupixent Receives FDA Priority Review for COPD Indication Extension

CompanyDeals

Kexing Pharmaceutical Partners with Yabao to Distribute Generic Nexavar in Ten Countries

Policy / Regulatory

Fujian Province Issues Provisional Regulations for Managing Medical Representative Visits

CompanyDrug

GenScript’s Subsidiary Legend Biotech Gets CHMP Nod for Carvykti Label Expansion in Multiple Myeloma

CompanyDrug

Celltrion’s Infliximab Biosimilar Shows Promising Long-Term Efficacy and Safety in CD and UC

CompanyDrug

Takeda’s Recombinant Pig FVIII Drug for Acquired Hemophilia A Approved in China

CompanyDeals

Mabwell Bioscience Cancels Licensing Agreements with Yangtze River Pharma for Two Drug Candidates

CompanyDrug

Mabwell Bioscience’s Nectin-4 Targeting ADC Earns FDA Fast-Track Designation for Esophageal Cancer

CompanyDeals

Boehringer-Ingelheim Partners with CBmed to Accelerate First-in-Class Cancer Medicines Development